Paper Details
- Home
- Paper Details
Montelukast and Nightmares: Further Characterisation Using Data from VigiBase.
Author: AttallaMarian, KaminskyElenor, TaavolaHenric, WatsonSarah, YueQun-Ying
Original Abstract of the Article :
Montelukast is a medicine indicated for use in asthma. Psychiatric disorders including nightmares have not been described in clinical trials but during recent years have been included in the product information as having been reported post-marketing, without further description of the events. Previo...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189082/
データ提供:米国国立医学図書館(NLM)
Montelukast and Nightmares: A Deeper Dive into a Potential Side Effect
Montelukast, a widely used medication for [asthma], has shown its effectiveness in managing respiratory symptoms. However, this research explores a potential [adverse effect] associated with montelukast: [nightmares]. The authors analyze data from [VigiBase], a global database of adverse drug reactions, to investigate the frequency and characteristics of nightmare reports linked to montelukast.
Montelukast and Nightmares: A Growing Concern
The analysis of data from VigiBase reveals a [growing number of reports] linking montelukast to nightmares. While this side effect was not initially identified in clinical trials, it has emerged as a potential issue following [post-marketing surveillance]. The research highlights the importance of [continued monitoring] of medications to identify potential adverse effects that may not be apparent in initial clinical trials.
Navigating Asthma Treatment: Understanding Potential Side Effects
Asthma is a chronic condition that requires [ongoing management] to control symptoms. This research emphasizes the importance of [open communication] between patients and healthcare providers regarding potential side effects of asthma medications. By understanding the potential risks of different treatments, individuals can make informed decisions about their asthma management plan and minimize the impact of any adverse effects.
Dr.Camel's Conclusion
This research, like a desert traveler's journey, reveals that even seemingly familiar paths can hold unexpected challenges. While montelukast has proven its effectiveness for asthma, it's important to recognize that, like a mirage in the desert, potential side effects can appear unexpectedly. By staying vigilant and openly communicating with healthcare providers, individuals can manage their asthma effectively while minimizing the impact of any potential side effects.
Date :
- Date Completed 2022-06-14
- Date Revised 2022-07-16
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.